Ekocorp

Ekocorp EBIT Growth

The Year-over-Year EBIT Growth of Ekocorp (EKOCORP.NL) as of Oct 22, 2026 is -20.88 %. In the previous year, Year-over-Year EBIT Growth was -22.68 % — a change of -7.93% (higher).

EBIT Growth

-20.88 %

YoY

-7.93%

Last updated:

Year-over-Year EBIT Growth of Ekocorp is 2020 -20.88 % . Year-over-Year EBIT Growth of Ekocorp was 2019 -22.68 % . It decreases by -7.93% higher compared to the previous year.

The Ekocorp EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2016
-45.04 NGN
Jan 1, 2017
-81.31 NGN
Jan 1, 2018
-1,220.78 NGN
Jan 1, 2019
-22.68 NGN
Jan 1, 2020
-20.88 NGN
The Ekocorp EBIT Growth history
YEAREBIT GrowthYoY
-20.88 %-7.93%
-22.68 %-98.14%
-1,220.78 %+1,401.40%
-81.31 %+80.54%
-45.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ekocorp Stock analysis

What does Ekocorp do? Ekocorp PLC provides healthcare services through its segments including standalone facilities, capitation models, and strategic business units such as general outpatients, nursing, intensive care, medical, obstetrics and gynaecology, paediatrics, radiology, and surgery. The company offers specialized medical services like dietician, diabetic nurse educator, foot care specialist, and consultant ophthalmologist. Its consultant services encompass general surgery, orthopaedic surgery, grammatology, otorhinolaryngology, audiology, speech therapy, dental surgery, ophthalmology, radiology, physical medicine (Physiotherapy), endoscopy, anaesthesia, obstetrics and gynaecology, radiotherapy, and oncology. Ekocorp also provides immunological screening services including thyroid antibodies, thyroid adrenal anti-nuclear antibodies, and paediatric endocrinology. The firm targets patients seeking specialized medical care and preventive health services. Its services are delivered through its healthcare delivery model focused on standard medical care and anchor services. Ekocorp's strategic business units serve diverse patient needs across various medical specialties. The company's offerings include both outpatient and inpatient care through its structured segments. Ekocorp PLC's revenue streams come from medical service fees charged to patients and healthcare providers. The company generates income through its consultant services, specialized medical care, and immunological screening services. Its business model relies on delivering high-quality healthcare services across multiple specialties to a broad patient base. The firm's segments operate under a unified healthcare delivery framework that supports its service offerings. Ekocorp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ekocorp stock

Year-over-Year EBIT Growth of Ekocorp is -20.88 % in 2020.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth Ekocorp since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's Ekocorp historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Ekocorp

All Key Metrics — Ekocorp